Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
2.190
-0.060 (-2.67%)
At close: Aug 21, 2025, 4:00 PM
2.170
-0.020 (-0.91%)
After-hours: Aug 21, 2025, 7:29 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $148.40 million as of August 21, 2025. Its market cap has decreased by -71.44% in one year.
Market Cap
148.40M
Enterprise Value
-37.68M
1-Year Change
-71.44%
Ranking
Category
Stock Price
2.19
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $148.40M, a decrease of -63.19%. That is a compound annual growth rate of -21.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 152.47M | 26.00% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | 403.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.23B |
| Johnson & Johnson | 430.92B |
| AbbVie | 370.09B |
| UnitedHealth Group | 274.74B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.74B |